Tenet Healthcare (NYSE:THC) Director J Robert Kerrey Sells 12,010 Shares

Tenet Healthcare Corporation (NYSE:THC) Director J. Robert Kerrey sold 12,010 shares of the company’s stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the completion of the transaction, the director owned 4,794 shares of the company’s stock, valued at approximately $1,264,273.68. This trade represents a 71.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Tenet Healthcare Stock Performance

THC stock opened at $265.56 on Thursday. The company has a 50-day simple moving average of $248.41 and a 200 day simple moving average of $212.79. The company has a market capitalization of $21.38 billion, a P/E ratio of 10.24, a PEG ratio of 0.99 and a beta of 1.23. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. Tenet Healthcare Corporation has a fifty-two week low of $157.58 and a fifty-two week high of $283.05.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the firm earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Sell-side analysts predict that Tenet Healthcare Corporation will post 21.04 earnings per share for the current fiscal year.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Strong analyst and quantitative support: Zacks highlighted Tenet among hospital operators benefiting from steady healthcare demand and improved efficiency. THC was also added to Zacks’ Rank #1 “Strong Buy” lists for both growth and value stocks, reinforcing the view that its earnings outlook and valuation remain attractive. 3 Hospital Stocks Riding Strong Demand and Improved Efficiency Best Growth Stocks to Buy for September 16th Best Value Stocks to Buy for September 16th
• Positive Sentiment: Potential undervaluation and earnings momentum: Zacks’ latest analysis points to favorable value, growth and momentum characteristics. That view is supported by Tenet’s latest quarterly results, which exceeded earnings and revenue estimates, with revenue increasing year over year. Are Investors Undervaluing Tenet Healthcare
• Positive Sentiment: Ambulatory strategy remains a strength: Coverage of United Surgical Partners International, Tenet’s ambulatory surgery platform, keeps attention on outpatient care, an area that can support more efficient growth and portfolio optimization. Tenet’s full-year 2026 EPS guidance and predominantly positive analyst ratings also support the bullish case. 5 Things to Know About United Surgical Partners International
• Neutral Sentiment: Restructuring creates mixed implications: Tenet’s $2.7 billion Conifer breakup is reportedly leading to 1,037 job cuts. The separation could streamline operations and sharpen strategic focus, but the near-term workforce reduction highlights execution and restructuring risks. Tenet’s $2.7B Conifer Breakup Triggers 1,037 Job Cuts
• Negative Sentiment: Director stock sale: Director Richard Mark sold 10,000 THC shares for approximately $2.6 million, reducing his position by 28.47%. The transaction is relatively small compared with Tenet’s market value but may weigh modestly on sentiment because it represents insider selling. Richard Mark Sells 10,000 Shares of Tenet Healthcare

Analyst Upgrades and Downgrades

Several brokerages have weighed in on THC. Robert W. Baird upped their target price on Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 28th. Weiss Ratings raised Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 20th. Royal Bank Of Canada raised their price objective on shares of Tenet Healthcare from $236.00 to $283.00 and gave the company an “outperform” rating in a research report on Monday, July 27th. TD Cowen lifted their target price on shares of Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a research note on Monday, July 27th. Finally, Wells Fargo & Company increased their price target on shares of Tenet Healthcare from $231.00 to $281.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $275.53.

Institutional Trading of Tenet Healthcare

Several hedge funds have recently modified their holdings of THC. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare during the 4th quarter worth $29,000. Trust Co. of Vermont acquired a new position in Tenet Healthcare in the second quarter valued at about $37,000. OP Asset Management Ltd acquired a new stake in shares of Tenet Healthcare during the first quarter worth about $49,000. Compass Financial Management LLC bought a new position in shares of Tenet Healthcare during the 2nd quarter valued at about $57,000. Finally, William B. Walkup & Associates Inc. grew its position in shares of Tenet Healthcare by 88.7% in the 4th quarter. William B. Walkup & Associates Inc. now owns 302 shares of the company’s stock valued at $60,000 after purchasing an additional 142 shares during the period. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company that owns and operates acute care hospitals and other healthcare facilities in the United States. Its hospitals provide services including emergency care, surgery, cardiovascular care, orthopedics, oncology, women’s health and other inpatient and outpatient treatments.

Through its ambulatory business, United Surgical Partners International, Tenet operates and manages ambulatory surgery centers and other outpatient facilities.